You are here

C-MOTION, INC.

Company Information
Address
20030 Century Blvd, Ste 104A
GERMANTOWN, MD 20874-1112
United States


http://www.c-motion.com

Information

UEI: GJPLU1M2BUE5

# of Employees: 8


Ownership Information

HUBZone Owned: No

Socially and Economically Disadvantaged: No

Woman Owned: No



Award Charts




Award Listing

  1. A PCR-BASED DNA TYPING SYSTEM

    Amount: $50,000.00

    N/A

    SBIRPhase I1990Department of Health and Human Services
  2. A DNA PROBE TEST FOR DEBRISOQUINE HYDROXYLASE PHENOTYPE

    Amount: $50,000.00

    N/A

    SBIRPhase I1990Department of Health and Human Services
  3. ANALYSIS OF YEAST GLYCOSYLATION OF A HUMAN GLYCOPROTEIN

    Amount: $227,000.00

    WE PROPOSE TO USE THE GENE FOR ALPHA-1-ANTI-TRYPSIN (1-AT), A MODERATELY GLYCOSYLATED HUMAN SERUM PROTEIN, AS A SPECIFIC MODEL TO TEST THE FEASIBILITY OF USING BAKERS' YEAST (S. CEREVISIAE) AS A HOST ...

    SBIRPhase II1987Department of Health and Human Services
  4. EXPERIENCE WITH THE CLONING AND EXPRESSION OF CLONED GENES IN SACCHAROMYCES CEREVISIAE SUGGESTS THAT THE RECOVERED YIELD OF CORRECTLY FOLDED PROTEIN PRODUCT IS GREATLY IMPROVED BY THE USE OF A YEAST-SECRETION PROCESS.

    Amount: $50,000.00

    EXPERIENCE WITH THE CLONING AND EXPRESSION OF CLONED GENES IN SACCHAROMYCES CEREVISIAE SUGGESTS THAT THE RECOVERED YIELD OF CORRECTLY FOLDED PROTEIN PRODUCT IS GREATLY IMPROVED BY THE USE OF A YEAST-S ...

    SBIRPhase I1986Department of Health and Human Services
  5. TESTING ITS IMMUNOTHERAPEUTIC POTENTIAL THE LONG-TERM OBJECTIVE OF THIS PROJECT IS TO DEVELOP PROCESSES FOR THE PRODUCTION OF B-CELL GROWTH FACTOR (BCGF) AND TO TEST THE POTENTIAL APPLICATIONS OF BCGF FOR THE TREATMENT OF HUMAN IMMUNOPATHOLOGICAL

    Amount: $50,000.00

    TESTING ITS IMMUNOTHERAPEUTIC POTENTIAL THE LONG-TERM OBJECTIVE OF THIS PROJECT IS TO DEVELOP PROCESSES FOR THE PRODUCTION OF B-CELL GROWTH FACTOR (BCGF) AND TO TEST THE POTENTIAL APPLICATIONS OF BCGF ...

    SBIRPhase I1985Department of Health and Human Services
  6. THE OBJECTIVE OF THIS RESEARCH PLAN IS TO ISOLATE A CDNA SEQUENCE ENCODING TUMOR NECROSIS FACTOR (TNF) AND, BY MANIPULATION OF THAT SEQUENCE, TO PRODUCE AND SECRETE THE MATURE TNF PROTEIN FROM THE YEAST SACCHAROMYCES CEREVISIAE.

    Amount: $50,000.00

    THE OBJECTIVE OF THIS RESEARCH PLAN IS TO ISOLATE A CDNA SEQUENCE ENCODING TUMOR NECROSIS FACTOR (TNF) AND, BY MANIPULATION OF THAT SEQUENCE, TO PRODUCE AND SECRETE THE MATURE TNF PROTEIN FROM THE YEA ...

    SBIRPhase I1985Department of Health and Human Services
  7. LYMPHOTOXIN IS A LYMPHOKINE WHICH HAS POTENT ANTITUMOR ACTIVITY.

    Amount: $50,000.00

    LYMPHOTOXIN IS A LYMPHOKINE WHICH HAS POTENT ANTITUMOR ACTIVITY. IT IS A GLYCOPROTEIN WITH A MOLECULAR WEIGHT OF 25,000 DALTONS. DUE TO THE MINUTE AMOUNT PRODUCED BY LYMPHOCYTES, EVALUATION OF ITS PHA ...

    SBIRPhase I1985Department of Health and Human Services
  8. WE PROMISE TO DEVELOP METHODS FOR THE LARGE-SCALE PRODUCTION OF HUMAN COLONY STIMULATING FACTORS (CSF) FROM NORMAL HUMAN PERIPHERAL BLOOD LYMPHOCYTES.

    Amount: $50,000.00

    WE PROMISE TO DEVELOP METHODS FOR THE LARGE-SCALE PRODUCTION OF HUMAN COLONY STIMULATING FACTORS (CSF) FROM NORMAL HUMAN PERIPHERAL BLOOD LYMPHOCYTES. THE FERMENTATION METHODS EMPLOYED WILL BE SIMILAR ...

    SBIRPhase I1985Department of Health and Human Services
  9. WE PROPOSE TO DEVELOP A METHODOLOGY BY WHICH THE GENES CODING FOR AUTOIMMUNE DISEASE-SPECIFIC PROTEIN ANTIGENS CAN BE RAPIDLY CLONED USING RECOMBINANT DNA TECHNIQUES.

    Amount: $50,000.00

    WE PROPOSE TO DEVELOP A METHODOLOGY BY WHICH THE GENES CODING FOR AUTOIMMUNE DISEASE-SPECIFIC PROTEIN ANTIGENS CAN BE RAPIDLY CLONED USING RECOMBINANT DNA TECHNIQUES. THE SYSTEM WHICH WE ARE USING LEN ...

    SBIRPhase I1985Department of Health and Human Services
  10. WE PROPOSE TO IDENTIFY THE GENES FOR AUTOIMMUNE DISEASE-SPECIFIC PROTEIN ANTIGENS BY THE USE OF RECOMBINANT DNA TECHNIQUES.

    Amount: $50,000.00

    WE PROPOSE TO IDENTIFY THE GENES FOR AUTOIMMUNE DISEASE-SPECIFIC PROTEIN ANTIGENS BY THE USE OF RECOMBINANT DNA TECHNIQUES. THE SYSTEM THAT WE ARE USING LENDS ITSELF TO HIGH-LEVEL EXPRESSION OF THESE ...

    SBIRPhase I1985Department of Health and Human Services
US Flag An Official Website of the United States Government